Denial-of-Service Vulnerability of Hash-based Transaction Sharding: Attacks and Countermeasures

Since 2016, sharding has become an auspicious solution to tackle the scalability issue in legacy blockchain systems. Despite its potential to strongly boost the blockchain throughput, sharding comes with its own security issues. To ease the process of deciding which shard to place transactions, existing sharding protocols use a hash-based transaction sharding in which the hash value of a transaction determines its output shard. Unfortunately, we show that this mechanism opens up a loophole that could be exploited to conduct a single-shard flooding attack, a type of Denial-of-Service (DoS) attack, to overwhelm a single shard that ends up reducing the performance of the system as a whole. To counter the single-shard flooding attack, we propose a countermeasure that essentially eliminates the loophole by rejecting the use of hash-based transaction sharding. The countermeasure leverages the Trusted Execution Environment (TEE) to let blockchain's validators securely execute a transaction sharding algorithm with a negligible overhead. We provide a formal specification for the countermeasure and analyze its security properties in the Universal Composability (UC) framework. Finally, a proof-of-concept is developed to demonstrate the feasibility and practicality of our solution

NeuCEPT: Locally Discover Neural Networks' Mechanism via Critical Neurons Identification with Precision Guarantee

Despite recent studies on understanding deep neural networks (DNNs), there exists numerous questions on how DNNs generate their predictions. Especially, given similar predictions on different input samples, are the underlying mechanisms generating those predictions the same? In this work, we propose NeuCEPT, a method to locally discover critical neurons that play a major role in the model's predictions and identify model's mechanisms in generating those predictions. We first formulate a critical neurons identification problem as maximizing a sequence of mutual-information objectives and provide a theoretical framework to efficiently solve for critical neurons while keeping the precision under control. NeuCEPT next heuristically learns different model's mechanisms in an unsupervised manner. Our experimental results show that neurons identified by NeuCEPT not only have strong influence on the model's predictions but also hold meaningful information about model's mechanisms.Comment: 6 main page

XRand: Differentially Private Defense against Explanation-Guided Attacks

Recent development in the field of explainable artificial intelligence (XAI) has helped improve trust in Machine-Learning-as-a-Service (MLaaS) systems, in which an explanation is provided together with the model prediction in response to each query. However, XAI also opens a door for adversaries to gain insights into the black-box models in MLaaS, thereby making the models more vulnerable to several attacks. For example, feature-based explanations (e.g., SHAP) could expose the top important features that a black-box model focuses on. Such disclosure has been exploited to craft effective backdoor triggers against malware classifiers. To address this trade-off, we introduce a new concept of achieving local differential privacy (LDP) in the explanations, and from that we establish a defense, called XRand, against such attacks. We show that our mechanism restricts the information that the adversary can learn about the top important features, while maintaining the faithfulness of the explanations.Comment: To be published at AAAI 202

Active Membership Inference Attack under Local Differential Privacy in Federated Learning

Federated learning (FL) was originally regarded as a framework for collaborative learning among clients with data privacy protection through a coordinating server. In this paper, we propose a new active membership inference (AMI) attack carried out by a dishonest server in FL. In AMI attacks, the server crafts and embeds malicious parameters into global models to effectively infer whether a target data sample is included in a client's private training data or not. By exploiting the correlation among data features through a non-linear decision boundary, AMI attacks with a certified guarantee of success can achieve severely high success rates under rigorous local differential privacy (LDP) protection; thereby exposing clients' training data to significant privacy risk. Theoretical and experimental results on several benchmark datasets show that adding sufficient privacy-preserving noise to prevent our attack would significantly damage FL's model utility.Comment: Published at AISTATS 202

Tin Dioxide Nanocrystals as an Effective Sensitizer for Erbium Ions in Er-Doped SnO 2

Undoped SnO2 and erbium-doped SnO2 powders were successfully prepared by precipitation method. The effect of the heat treatment and doping contents on the structure of tin oxide and optical properties was also studied. The XRD data and Raman spectra indicate that the SnO2 crystals have formed after being heat-treated at 400°C and the average size of grains is about 8 nm for doping content of 1 mol%. An increase of doping concentration has controlled the growth of nanocrystals. The principle of the visible and infrared emissions of SnO2 and SnO2:Er is also discussed. All photoluminescence study shows that the Er3+ ions can be located in SnO2 nanocrystals and that there is energy transfer from defect levels of SnO2 nanoparticles to neighboring Er3+ ions of crystals

Non-coding RNAs versus protein biomarkers to diagnose and differentiate acute stroke:Systematic review and meta-analysis

BACKGROUND: Stroke diagnosis is dependent on lengthy clinical and neuroimaging assessments, while rapid treatment initiation improves clinical outcome. Currently, more sensitive biomarker assays of both non-coding RNA- and protein biomarkers have improved their detectability, which could accelerate stroke diagnosis. This systematic review and meta-analysis compares non-coding RNA- with protein biomarkers for their potential to diagnose and differentiate acute stroke (subtypes) in (pre-)hospital settings.METHODS: We performed a systematic review and meta-analysis of studies evaluating diagnostic performance of non-coding RNA- and protein biomarkers to differentiate acute ischemic and hemorrhagic stroke, stroke mimics, and (healthy) controls. Quality appraisal of individual studies was assessed using the QUADAS-2 tool while the meta-analysis was performed with the sROC approach and by assessing pooled sensitivity and specificity, diagnostic odds ratios, positive- and negative likelihood ratios, and the Youden Index.SUMMARY OF REVIEW: 112 studies were included in the systematic review and 42 studies in the meta-analysis containing 11627 patients with ischemic strokes, 2110 patients with hemorrhagic strokes, 1393 patients with a stroke mimic, and 5548 healthy controls. Proteins (IL-6 and S100 calcium-binding protein B (S100B)) and microRNAs (miR-30a) have similar performance in ischemic stroke diagnosis. To differentiate between ischemic- or hemorrhagic strokes, glial fibrillary acidic protein (GFAP) levels and autoantibodies to the NR2 peptide (NR2aAb, a cleavage product of NMDA neuroreceptors) were best performing whereas no investigated protein or non-coding RNA biomarkers differentiated stroke from stroke mimics with high diagnostic potential.CONCLUSIONS: Despite sampling time differences, circulating microRNAs (&lt; 24 h) and proteins (&lt; 4,5 h) perform equally well in ischemic stroke diagnosis. GFAP differentiates stroke subtypes, while a biomarker panel of GFAP and UCH-L1 improved the sensitivity and specificity of UCH-L1 alone to differentiate stroke.</p

Sex Differences in Prehospital Identification of Large Vessel Occlusion in Patients with Suspected Stroke

BACKGROUND: Differences in clinical presentation of acute ischemic stroke between men and women may affect prehospital identification of anterior circulation large vessel occlusion (aLVO). We assessed sex differences in diagnostic performance of 8 prehospital scales to detect aLVO. METHODS: We analyzed pooled individual patient data from 2 prospective cohort studies (LPSS [Leiden Prehospital Stroke Study] and PRESTO [Prehospital Triage of Patients With Suspected Stroke Study]) conducted in the Netherlands between 2018 and 2019, including consecutive patients ≥18 years suspected of acute stroke who presented within 6 hours after symptom onset. Ambulance paramedics assessed clinical items from 8 prehospital aLVO detection scales: Los Angeles Motor Scale, Rapid Arterial Occlusion Evaluation, Cincinnati Stroke Triage Assessment Tool, Cincinnati Prehospital Stroke Scale, Prehospital Acute Stroke Severity, gaze-face-arm-speech-time, Conveniently Grasped Field Assessment Stroke Triage, and Face-Arm-Speech-Time Plus Severe Arm or Leg Motor Deficit. We assessed the diagnostic performance of these scales for identifying aLVO at prespecified cut points for men and women.RESULTS: Of 2358 patients with suspected stroke (median age, 73 years; 47% women), 231 (10%) had aLVO (100/1114 [9%] women and 131/1244 [11%] men). The area under the curve of the scales ranged from 0.70 (95% CI, 0.65-0.75) to 0.77 (95% CI, 0.73-0.82) in women versus 0.69 (95% CI, 0.64-0.73) to 0.75 (95% CI, 0.71-0.79) in men. Positive predictive values ranged from 0.23 (95% CI, 0.20-0.27) to 0.29 (95% CI, 0.26-0.31) in women versus 0.29 (95% CI, 0.24-0.33) to 0.37 (95% CI, 0.32-0.43) in men. Negative predictive values were similar (0.95 [95% CI, 0.94-0.96] to 0.98 [95% CI, 0.97-0.98] in women versus 0.94 [95% CI, 0.93-0.95] to 0.96 [95% CI, 0.94-0.97] in men). Sensitivity of the scales was slightly higher in women than in men (0.53 [95% CI, 0.43-0.63] to 0.76 [95% CI, 0.68-0.84] versus 0.49 [95% CI, 0.40-0.57] to 0.63 [95% CI, 0.55-0.73]), whereas specificity was lower (0.79 [95% CI, 0.76-0.81] to 0.87 [95% CI, 0.84-0.89] versus 0.82 [95% CI, 0.79-0.84] to 0.90 [95% CI, 0.88-0.91]). Rapid arterial occlusion evaluation showed the highest positive predictive values in both sexes (0.29 in women and 0.37 in men), reflecting the different event rates. CONCLUSIONS: aLVO scales show similar diagnostic performance in both sexes. The rapid arterial occlusion evaluation scale may help optimize prehospital transport decision-making in men as well as in women with suspected stroke.</p

Sex Differences in Prehospital Identification of Large Vessel Occlusion in Patients with Suspected Stroke

BACKGROUND: Differences in clinical presentation of acute ischemic stroke between men and women may affect prehospital identification of anterior circulation large vessel occlusion (aLVO). We assessed sex differences in diagnostic performance of 8 prehospital scales to detect aLVO. METHODS: We analyzed pooled individual patient data from 2 prospective cohort studies (LPSS [Leiden Prehospital Stroke Study] and PRESTO [Prehospital Triage of Patients With Suspected Stroke Study]) conducted in the Netherlands between 2018 and 2019, including consecutive patients ≥18 years suspected of acute stroke who presented within 6 hours after symptom onset. Ambulance paramedics assessed clinical items from 8 prehospital aLVO detection scales: Los Angeles Motor Scale, Rapid Arterial Occlusion Evaluation, Cincinnati Stroke Triage Assessment Tool, Cincinnati Prehospital Stroke Scale, Prehospital Acute Stroke Severity, gaze-face-arm-speech-time, Conveniently Grasped Field Assessment Stroke Triage, and Face-Arm-Speech-Time Plus Severe Arm or Leg Motor Deficit. We assessed the diagnostic performance of these scales for identifying aLVO at prespecified cut points for men and women.RESULTS: Of 2358 patients with suspected stroke (median age, 73 years; 47% women), 231 (10%) had aLVO (100/1114 [9%] women and 131/1244 [11%] men). The area under the curve of the scales ranged from 0.70 (95% CI, 0.65-0.75) to 0.77 (95% CI, 0.73-0.82) in women versus 0.69 (95% CI, 0.64-0.73) to 0.75 (95% CI, 0.71-0.79) in men. Positive predictive values ranged from 0.23 (95% CI, 0.20-0.27) to 0.29 (95% CI, 0.26-0.31) in women versus 0.29 (95% CI, 0.24-0.33) to 0.37 (95% CI, 0.32-0.43) in men. Negative predictive values were similar (0.95 [95% CI, 0.94-0.96] to 0.98 [95% CI, 0.97-0.98] in women versus 0.94 [95% CI, 0.93-0.95] to 0.96 [95% CI, 0.94-0.97] in men). Sensitivity of the scales was slightly higher in women than in men (0.53 [95% CI, 0.43-0.63] to 0.76 [95% CI, 0.68-0.84] versus 0.49 [95% CI, 0.40-0.57] to 0.63 [95% CI, 0.55-0.73]), whereas specificity was lower (0.79 [95% CI, 0.76-0.81] to 0.87 [95% CI, 0.84-0.89] versus 0.82 [95% CI, 0.79-0.84] to 0.90 [95% CI, 0.88-0.91]). Rapid arterial occlusion evaluation showed the highest positive predictive values in both sexes (0.29 in women and 0.37 in men), reflecting the different event rates. CONCLUSIONS: aLVO scales show similar diagnostic performance in both sexes. The rapid arterial occlusion evaluation scale may help optimize prehospital transport decision-making in men as well as in women with suspected stroke.</p